Variant report
Variant | esv3407522 |
---|---|
Chromosome Location | chr2:64570548-64574546 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238201 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550455474 | chr2:64570602-64570603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145784314 | chr2:64570683-64570684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148925896 | chr2:64570731-64570732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527329434 | chr2:64570860-64570861 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs184021661 | chr2:64570875-64570876 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs189671769 | chr2:64570911-64570912 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs547647769 | chr2:64570916-64570917 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs553241716 | chr2:64570952-64570953 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs143673531 | chr2:64570979-64570980 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs10203643 | chr2:64571011-64571012 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs146748986 | chr2:64571035-64571036 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs530015536 | chr2:64571045-64571046 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs575707176 | chr2:64571064-64571065 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs140378694 | chr2:64571116-64571117 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs549663942 | chr2:64571152-64571153 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs561301504 | chr2:64571159-64571160 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs528487574 | chr2:64571164-64571165 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs145576834 | chr2:64571179-64571180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10206155 | chr2:64571180-64571181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs181071878 | chr2:64571223-64571224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186055726 | chr2:64571235-64571236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs137979973 | chr2:64571250-64571251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537940319 | chr2:64571288-64571289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557877959 | chr2:64571297-64571298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546232039 | chr2:64571298-64571299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535968907 | chr2:64571446-64571447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190530872 | chr2:64571447-64571448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566171392 | chr2:64571480-64571481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533540258 | chr2:64571487-64571488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35476947 | chr2:64571497-64571498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs397984843 | chr2:64571499-64571500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558216536 | chr2:64571551-64571552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141736609 | chr2:64571595-64571596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374035583 | chr2:64571637-64571638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150111869 | chr2:64571669-64571670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138547251 | chr2:64571684-64571685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181868464 | chr2:64571702-64571703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533976331 | chr2:64571746-64571747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186356392 | chr2:64571788-64571789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149239551 | chr2:64571845-64571846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573330712 | chr2:64571849-64571850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79330974 | chr2:64571858-64571859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565100723 | chr2:64571867-64571868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115105982 | chr2:64571868-64571869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62136482 | chr2:64571936-64571937 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs543307733 | chr2:64571956-64571957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562737058 | chr2:64571991-64571992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190687382 | chr2:64572136-64572137 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs547928456 | chr2:64572140-64572141 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs182877143 | chr2:64572150-64572151 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:64568400-64575800 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr2:64569000-64572400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr2:64571600-64571800 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr2:64572200-64572600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr2:64572400-64572600 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr2:64572400-64572600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr2:64572600-64581800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr2:64573200-64573800 | Enhancers | A549 | lung |
9 | chr2:64573800-64576000 | Weak transcription | A549 | lung |